ArticleMethods in molecular biology (Clifton, N.J.)2025
3D Morphometry of Preclinical Bone Disease Models Beyond Osteoporosis.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Micro-CT is becoming a gold standard for quantitative imaging in preclinical disease models in bone research. Osteoporosis research routinely uses microCT for 3D analysis of the architecture and mechanical competence of trabecular and cortical bone. While most published methodological research on microCT in bone has focused on osteoporosis, there is equal potential for microCT to quantitatively assess other bone disease models (and genetic phenotypes). Here a unified analysis approach or "pipeline" is presented for all preclinical bone research models, consisting of a series of steps: (i) the scan and reconstruction; (ii) standardized 3D image orientation; (iii) anatomically referenced volume of interest (VOI) delineation; (iv) segmentation and 3D analysis, with (v) application-specific interpretation of measured parameters. How this pipeline works in practice is described for several applications beyond osteoporosis (covered elsewhere in this volume): arthritis bone effects, arthritis cartilage effects, bone tumor, and fracture callus healing. All these analyses can be performed in a single software environment and morphometry pipeline.
Indexed as
Identifiers
40448779What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.